Patents by Inventor James Schwing

James Schwing has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immediate release and sustained release ibuprofen dosing regimen
    Patent number: 8211465
    Abstract: A method of administering non-steroidal-anti-inflammatory drugs, in particular propionic acid derivatives such as ibuprofen, is provided. The inventive dosage forms provide an initial release of the NSAID and a second sustained release of NSAID, preferably in a single dosing step.
    Type: Grant
    Filed: February 7, 2012
    Date of Patent: July 3, 2012
    Assignee: McNeil-PPC, Inc.
    Inventors: Der-Yang Lee, Frank Bunick, James Schwing
  • IMMEDIATE RELEASE AND SUSTAINED RELEASE IBUPROFEN DOSING REGIMEN
    Publication number: 20120136060
    Abstract: A method of administering non-steroidal-anti-inflammatory drugs, in particular propionic acid derivatives such as ibuprofen, is provided. The inventive dosage forms provide an initial release of the NSAID and a second sustained release of NSAID, preferably in a single dosing step.
    Type: Application
    Filed: February 7, 2012
    Publication date: May 31, 2012
    Inventors: Der-Yang Lee, Frank Bunick, James Schwing
  • Immediate release and sustained release ibuprofen dosing regimen
    Patent number: 8137694
    Abstract: A method of administering non-steroidal-anti-inflammatory drugs, in particular propionic acid derivatives such as ibuprofen, is provided. The inventive dosage forms provide an initial release of the NSAID and a second sustained release of NSAID, preferably in a single dosing step.
    Type: Grant
    Filed: August 15, 2007
    Date of Patent: March 20, 2012
    Assignee: McNeil-PPC, Inc.
    Inventors: Der-Yang Lee, Frank Bunick, James Schwing
  • IMMEDIATE RELEASE AND SUSTAINED RELEASE IBUPROFEN DOSING REGIMEN
    Publication number: 20090048345
    Abstract: A method of administering non-steroidal-anti-inflammatory drugs, in particular propionic acid derivatives such as ibuprofen, is provided. The inventive dosage forms provide an initial release of the NSAID and a second sustained release of NSAID, preferably in a single dosing step.
    Type: Application
    Filed: August 15, 2007
    Publication date: February 19, 2009
    Inventors: Der-Yang Lee, Frank Bunick, James Schwing
  • Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends
    Patent number: 5451409
    Abstract: The present invention is directed to a novel sustained release matrix and oral dosage form comprising a homogeneous matrix formed from a wet granulation containing an effective amount of a medicament and a polymer blend of hydroxypropyl cellulose and hydroxyethyl cellulose. The present invention also discloses a novel process for making a sustained release oral dosage form comprising wet granulating a medicament with a polymer blend of hydroxypropyl cellulose and hydroxyethyl cellulose to form a homogeneous matrix, wherein the polymer blend is provided in an amount effective to control the release of said medicament, then forming the homogenous matrix into a solid oral dosage form.
    Type: Grant
    Filed: November 22, 1993
    Date of Patent: September 19, 1995
    Inventors: William F. Rencher, Suresh Babu, Shankar Musunuri, Christopher H. Day, James Schwing